Resources
Press Release, 21 December 2016
Kuros submits regulatory filing seeking CE certification for Neuroseal, a novel dural sealant
Press Release, 19 December 2016
Kuros to acquire Xpand in an all-share strategic transaction to create a leading commercial stage orthobiologics company
Press Release, 20 October 2016
Kuros Biosciences’ KUR-112 Receives Rare Pediatric Disease Designation
Press Release, 29 September 2016
Kuros Biosciences Reports Financial Results for First Half-Year of 2016
Kuros Interim Results, 2016
English version
Cytos Interim Results, 2015
English version